Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investors to buy and sell shares again. This development is important for shareholders and potential investors as it restores market activity for the company. For further details, investors are advised to check Nasdaq's official site or contact the company directly.
The Nasdaq resumption of CN Healthy Food Tech Group Corp. trading is noted here alongside Pluang's Consumer Staples sector data. For readers following this sector, here is Pluang's market snapshot as of Oct 16, 2026 21:12 WIB: out of 63 priced stocks, 57 rose and 6 fell. Notable movers include CELH at USD 29.14 with a 1-day change of +3.48%, and BTI at USD 59.52 with a 1-day change of +2.62%.
David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...
SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...
The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...
The Out of Home Advertising Association of America (OAAA) held the 84th Annual OBIE Awards in New York City, celebrating the best creative campaigns in out of home (OOH) advertising. Paramount was inducted into the OBIE Hall of Fame for its longstand...
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
